|Bid||9.78 x 1200|
|Ask||0.00 x 2900|
|Day's Range||23.65 - 24.60|
|52 Week Range||23.65 - 49.11|
|Beta (5Y Monthly)||0.61|
|PE Ratio (TTM)||12.01|
|Forward Dividend & Yield||0.01 (0.04%)|
|Ex-Dividend Date||Dec 14, 2021|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for OMI
While Owens & Minor, Inc. ( NYSE:OMI ) shareholders are probably generally happy, the stock hasn't had particularly...
Owens & Minor Inc (NYSE: OMII) reported second-quarter revenue of $2.50 billion, an increase of 0.44% year-over-year, missing the consensus of $2.54 billion. Adjusted EPS of $0.76 in Q2 was lower than $1.06 a year ago, matching the consensus of $0.76. Gross margin expanded by 523 bps to 21.3%. Adjusted operating income declined 1.7% Y/Y to $113.6 million, and the margin was 4.5%, down by 10 bps. Patient Direct revenue grew 145% Y/Y to $573 million, with Byram revenue growth of 17% and Apria pro
Owens & Minor (OMI) delivered earnings and revenue surprises of 0% and 3.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?